El Abasse Zeine, B. Rime, Ghali Benani, L. Azzouzi, Habbal Rachida
{"title":"Patent Foramen Ovale and Inherited Thrombophilia in the Pathogenesis of Arterial Thrombosis in a Young Patient: A Case Report and Literature Review","authors":"El Abasse Zeine, B. Rime, Ghali Benani, L. Azzouzi, Habbal Rachida","doi":"10.37532/ICRJ.2021.10(1).429","DOIUrl":"https://doi.org/10.37532/ICRJ.2021.10(1).429","url":null,"abstract":"Background: A Patent Foramen Ovale (PFO) is frequently associated with cryptogenic stroke in young patients with paradoxical embolism as the presumed mechanism. Moreover, hypercoagulable states that are known in the pathogenesis of venous thrombosis, can sometimes be found in patients with stroke, which can be explained by the PFO, that provides the missing link. The association between PFO and prothrombotic state may hence increase the risk for paradoxical embolism. Yet, the cause-and-effect relationship between these pathologies is not clearly established and the best therapeutic and preventive strategy are unelucidated. Case Report: We report a case associating ischemic stroke, left internal carotid occlusion, and pulmonary embolism with the discovery of a PFO and inherited thrombophilic disorders, in a young woman under combined contraceptives. Conclusion: We believe that this case is important since it shows the importance of searching for a PFO in young patients with arterial events and thrombophilia and also the interest of systematic screening for procoagulant disorders in those with stroke and PFO, and highlights the challenge in the multidisciplinary management of such patients.","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":"2021 1","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2021-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46482151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Cardiovascular Risk Research in Alzheimer’s Disease and Other Neurodegenerative Diseases","authors":"T. L. Sampaio, E. A. D. Siqueira","doi":"10.37532/ICRJ.2021.10(1).430","DOIUrl":"https://doi.org/10.37532/ICRJ.2021.10(1).430","url":null,"abstract":"The occurrence of chronic and neurodegenerative diseases is epidemiologically important in elderly population, including Alzheimer’s Disease (AD). Risk factors such as diabetes, obesity, hypertension, Cardiovascular Diseases (CVD), hyperlipidemia, hyperhomocysteinemia, and smoking can lead to Cerebrovascular Diseases (CBVD). The neurodegeneration is consequence of cumulative macro and microcirculatory damage, corroborating to increase in systolic pressure, neuroinflammation, oxidative stress, and excitotoxicity. There are some intersections between AD and CVD. For example, e4 allele of the Apolipoprotein E (APOE) gene is a risk; low plasma levels of ApoE protein favor the risk of AD, regardless of the APOE genotype. Furthermore, the insulin resistance causes atrophy of the white matter with loss of myelinated fibrils. These phenomena modify the function of the Blood-Brain Barrier (BBB), causing injury to pericytes and activation of the Cell Adhesion Molecule-1 (VCAM-1), Intercellular Adhesion Molecule-1 (ICAM-1) and E-selectin. In consequence, it is observed excitotoxicity, predisposing to ischemic stroke, activation of neuroinflammation, excessive production of Beta-Amyloid Protein (Aβ42) and aberrantly phosphorylated tau, activation of astrocytes evidenced by overexpression of Glial Fibrillar Acid Protein (GFAP), inhibition of neurotransmitter uptake, excessive depolarization of neurons efferent and decrease on expression of Brain-Derived Neurotrophic Factor (BDNF). Thus, future experimental and population-based studies are encouraged.","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":"2021 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2021-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43456730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Complementary supportive therapy for symptomatic patients with left ventricular dilatation and reduced ejection fraction","authors":"Mila Jakovljević","doi":"10.4172/2324-8602-C3-011","DOIUrl":"https://doi.org/10.4172/2324-8602-C3-011","url":null,"abstract":"Introduction of study was to assess the effect of complementary supportive therapy (CST) on the quality of life and functional capability in patients with heart failure and reduced ejection fraction (HFrEF). Patients and Methods : We investigated 33 patients with left ventricular dilatation (LVIDd> 60 mm) and reduced ejection fraction (EF <40%) in 76 complementary supportive therapy (CST) periods. Prior to each CST period, therapy was optimized (OMT) for one month. CST consists of a 10-day session. In addition to OMT, the patients were treated with carnitine, L-arginine, magnesium, thiamine, riboflavin, pantothenic acid, niacin, pyridoxal, biotin, lipoic acid, coenzyme Q-10, vitamin","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70244560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pulmonary Disorder in A Patient Recovering from Coronavirus Disease 2019 In Cardiac Surgery: Case Report and Review","authors":"M. Ghodrati, A. Amini, Omid Imani","doi":"10.37532/ICRJ.2020.9(6).419","DOIUrl":"https://doi.org/10.37532/ICRJ.2020.9(6).419","url":null,"abstract":"Covid-19 patients show a range of disturbance, the most significant of which is an acute respiratory syndrome. 17% -29% of them indicated more severe complications of pulmonary disorders including pneumonia and Acute Respiratory Distress Syndrome (ARDS). Preliminary studies have reported an increase in inflammatory mediators and cytokines (cytokine storm) in patients with COVID-19. A Cardiopulmonary Bypass (CPB) alone triggers a potent stimulant to release of inflammatory response throughout the body. The synergistic effect of COVID-19 and CPB development postoperative risks in cardiac surgery patients. The patient was a 53-year-old man with coronary artery disease. After the end of the CPB observed pulmonary dysfunction and decreased Partial pressure of oxygen (PO2) and O2 Saturation (O2sat) in Arterial Blood Gas (ABG). In Chest CT, the patient’s previous pulmonary lesions were exacerbated after surgery, and pneumonia was diagnosed based on the opinion of an infectious disease specialist.","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":" ","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2020-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45788825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of Extracardiac Intrathoracic Vascular Anomalies on CT Angiography In 254 Patients being Evaluated for Congenital Heart Disease and Comparison with Echocardiography","authors":"Reena An, N. Awasthy, K. S. Dagar, B. Aggarwal","doi":"10.37532/ICRJ.2020.9(6).418","DOIUrl":"https://doi.org/10.37532/ICRJ.2020.9(6).418","url":null,"abstract":"Background: To evaluate the advantage of CT Angiography (CTA) in diagnosis of extra cardiac vascular and non-vascular abnormalities in patients of congenital heart disease. Patients and Methods: This is a retrospective study wherein two hundred fifty four consecutive patients from January 2017 to December 2019 with known congenital heart disease who were referred for CTA as a part of their regular clinical work up were included. Findings of Echocardiography (ECHO) were also recorded. Results: The vascular anomalies on CTA were found in 191 patients giving an incidence of 75.1% with MAPCAs showed the highest incidence (34.61%). On ECHO vascular anomalies were found in 97 patients giving an incidence of 38.18%. Incidence of associated non-cardiovascular anomalies detected on CTA came out to be 16.4% The most common detected congenital heart disease was TOF on both CTA and ECHO. Although ASD and VSD are diagnosed on Echo, CTA was performed in these cases as a part of the comprehensive workup. CTA significantly outperformed ECHO in the detection of vascular anomalies eg. PDA and COA. Rests of the CHD detection were equal in CTA and ECHO. Conclusion: As patients of congenital heart diseases also present with a wide range of associated extra cardiac vascular findings which range from non-significant to those affecting the clinical outcome of patients. Assessment of extra-cardiac vessels is mandatory at the time of performing these studies since these findings are important for giving a complete diagnosis and for treatment planning in some cases. CTA also detects incidental non-cardiovascular anomalies which can affect the treatment planning of that patient.","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":"2020 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2020-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48032662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Short Note on Arrhythmia","authors":"Ashwini Mattapalli","doi":"10.37532/ICRJ.2020.9(5).413","DOIUrl":"https://doi.org/10.37532/ICRJ.2020.9(5).413","url":null,"abstract":"The heart is the central organ of the body. The heart supplies blood to every part of the body as result carrying the oxygen and exchanging it with the co2 and helping the respiratory system. The heart never stops its beat if it happens then the condition leads to death. The healthy heart beat every second the doctor identifies the heart beat by counting the number of times the heart beats every minute when the person in in the resting phase. It usually varies from every single individual. The healthy heart beat is usually between 60 and 100 beats for minute. Heart rate can also be measured through their pulse at different locations like wrist, insides of the elbows, side of the neck and top of the foot.","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":" ","pages":"1-1"},"PeriodicalIF":0.0,"publicationDate":"2020-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47530622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cardiovascular Research at COVID-19","authors":"T. L. Sampaio, R. Menezes","doi":"10.37532/ICRJ.2020.9(5).412","DOIUrl":"https://doi.org/10.37532/ICRJ.2020.9(5).412","url":null,"abstract":"Year 2020 is a historic year for society and challenging for science. With the rise of COVID-19 pandemic, several research groups around the world have studied the structure of the causative virus, potential new drugs, drugs candidates for repurposing, vaccines, and methods of management of the main complications caused by the disease. The new coronavirus can cause several organic complications in respiratory, nervous, urinary, hepatobiliary tissues and bloodstream. Among these complications, it is important to highlight the cardiovascular disorders, since patients with heart disease, systemic arterial hypertension, congestive heart failure, metabolic syndrome and diabetes are some of the main risk groups. In a global alert scenario, the social importance of scientists in cardiovascular research is ratified. Therefore, several research groups have sought strategies aiming the early diagnosis of cardiovascular complications in patients with COVID-19. Additionally, different patient management protocols in intensive care have been designed and constantly revised, which could improve life quality of these patients and minimize mortality rates. Therefore, this editorial for the International Journal of Cardiovascular Research aims to reinforce the importance of research in the area, congratulate the scientists for their efforts in these turbulent times and encourage new studies on this topic, suggesting new experimental and clinical paths.","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":"9 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2020-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42512739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Therapies in the Treatment of Heart Failure","authors":"Mamatha Dereddy","doi":"10.37532/ICRJ.2020.9(5).414","DOIUrl":"https://doi.org/10.37532/ICRJ.2020.9(5).414","url":null,"abstract":"Heart failure is a condition where your heart doesn’t pump blood as well as it should. The heart failure generally starts with the buildup of the plaque and their by thickening the artery walls mainly the heart’s pumping chamber the left ventricle. In the ancient days there is no treatment for heart failure as a reason it lead to many deaths but now in the present medical advancements many new treatments are available to improve your quality of life. According to the Society for Cardiovascular Angiography and Interventions bypass surgery and percutaneous balloon angioplasty were the only treatments available for the treatment of many heart diseases. Later then stents played a major role.","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":" ","pages":"1-1"},"PeriodicalIF":0.0,"publicationDate":"2020-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46602247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Papillary Muscle Noncompaction: A Unique Mechanism for Mitral Regurgitation in Children","authors":"Sulafa K M Ali, Laila M Elmahdi","doi":"10.37532/ICRJ.2020.9(5).411","DOIUrl":"https://doi.org/10.37532/ICRJ.2020.9(5).411","url":null,"abstract":"Background: Noncompaction Cardiomyopathy (NCCM) is a primary genetic cardiomyopathy with variable clinical and Echocardiographic (echo) features. Association with Mitral Regurgitation (MR) was reported but the mechanism of this association has not been well described in pediatric patients. Aims: To describe clinical and echo features of MR in NCCM. Methods: All pediatric patients with NCCM associated with MR and preserved ventricle function seen in one center from January 2015 to March 2020 were included. Clinical and echo features were described. Results: Twelve patients were identified (66% females), 8 (66%) presented with heart failure due to severe MR , and 4 were asymptomatic with mild-moderate MR. Echo features in all patients showed Papillary Muscle Noncompaction (PMNC). The Papillary Muscle (PM) base was discontinuous with the endocardium in 5 patients (41%) and PM were not well differentiated from the noncompacted myocardium in 3 patients (25%)There were variable degrees of chordal elongation and malcoaptation of the leaflets in all patients. Five patients (41%) had associated congenital heart disease including ventricular septal defects in 4 and patent ductus arteriosus in one patient. Conclusion: PMNC causes MV chordal abnormalities that lead to malcoaptation of the mitral leaflets resulting in MR. NCCM needs to be considered when evaluating patients with MR.","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":" ","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2020-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45044792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bronchial artery Aneurysm Diagnosis and Treatment","authors":"Mamatha Dereddy, A. Paladugu","doi":"10.37532/ICRJ.2020.9(5).410","DOIUrl":"https://doi.org/10.37532/ICRJ.2020.9(5).410","url":null,"abstract":"Bronchial artery aneurism could be a rare vascular abnormality, with associate degree incidence of <1% supported diagnosing by selective CT angiograpgy. It’s manifested in varied forms, starting from associate degree incidental finding on radiologic examination to serious hemorrhage ensuing from aneurism rupture. These pulmonary arteries provide deoxygenated blood at an awfully low pressure. These blood vessels provide ninety nine of the blood flow to the lungs and will do the gas exchange at the alveolar capillary membrane.","PeriodicalId":89940,"journal":{"name":"International journal of cardiovascular research","volume":"2020 1","pages":"1-1"},"PeriodicalIF":0.0,"publicationDate":"2020-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45209776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}